Table 2

Hospital admissions and use of hospital resources in the last 3 months before death of patients with different haematological malignancies

Total study populationAcute leukaemiaChronic lymphoid leukaemiaChronic myeloid leukaemiaHodgkin’s lymphomaMultiple myelomaMyelo-dysplastic syndromesNon-Hodgkin’s lymphoma
n=46 629n=11 531n=4161n=1157n=1022n=8803n=6693n=13 262
Hospital admissions
 Number of hospital admissions (mean, SD)*2.1 (1.6)2.2 (1.8)2.0 (1.6)2.0 (1.8)2.0 (1.4)2.0 (1.5)2.1 (1.7)2.1 (1.5)
 Number of days of hospitalisation (mean, SD)†34.9 (25.5)30.9 (23.7)32.5 (25.3)33.1 (26.3)38.7 (27.5)35.2 (25.5)34.9 (25.5)38.9 (26.1)
 Continuous hospitalisation during last 3 months (%)‡3.2%1.8%3.0%3.9%5.2%3.6%3.3%3.9%
Emergency department visits (%)‡
 041.6%41.0%39.0%36.8%44.5%43.4%36.4%44.6%
 143.0%43.3%45.2%47.0%42.1%42.6%43.2%42.1%
 212.2%12.1%12.5%12.6%11.3%11.3%15.5%11.1%
 ≥33.2%3.6%3.4%3.7%2.1%2.6%5.0%2.2%
Provenance of the last hospital admission (%)‡
 Transfer from another unit or facility23.6%18.9%20.3%24.5%27.6%24.4%21.1%29.1%
 Admission through the emergency department36.9%37.6%42.8%39.7%34.5%35.6%42.8%32.2%
 Admission from home38.5%42.6%35.8%34.1%37.1%39.1%34.9%37.8%
 Admission from nursing homes0.5%0.3%0.7%0.7%0.5%0.4%0.7%0.4%
 Admission from hospital-at-home services0.5%0.6%0.3%1.0%0.2%0.6%0.4%0.5%
Place of death (%)‡
 Emergency department2.0%2.2%2.4%2.5%1.4%1.9%2.1%1.6%
 Palliative care unit5.5%6.3%3.3%5.1%3.4%5.8%4.1%6.4%
 Intensive care unit18.1%15.8%24.4%26.0%27.5%15.8%21.7%16.3%
 Other acute care unit63.4%68.0%59.6%53.8%55.4%64.1%61.2%62.6%
 Rehabilitation care unit11.1%7.8%10.4%12.6%12.4%12.4%10.8%13.2%
  • Sex-standardised and age-standardised values, using the total study population as reference.

  • *P<0.001 (Wilcoxon rank sum test).

  • †P<0.001 (Student’s t-test).

  • ‡P<0.001 (Pearson’s χ2 test).